/
/
What are Bispecific Antibodies and How are They Used in Treating Multiple Myeloma?
What are Bispecific Antibodies and How are They Used in Treating Multiple Myeloma? image
What are Bispecific Antibodies and How are They Used in Treating Multiple Myeloma?
Posted May 03, 2022

HealthTree University: Immunotherapy Antibodies 2/2

What are bispecific antibodies and how are they used in treating multiple myeloma? Find out below to see if bispecific antibodies are being used in myeloma and if there any bispecific antibodies that are FDA approved. We've assembled this course which features the top world experts on immunotherapy to teach you about these latest advances in myeloma research. You can watch the entire course on HealthTree University.

15.05    What are bispecific antibodies?

 

15.06    Are there any bispecific antibodies that are FDA approved?

 

We’d like to thank our faculty who donated their time in creating these videos, including:

  • Ravi Vij, MD, MBA
  • David Vesole, MD, PhD
  • Luciano Costa, MD, PhD
  • Peter Voorhees, MD

Want more?

We have over 500 HealthTree University videos online at HealthTree University! Learn the basics (and the not-so-basics) of myeloma from some of the top myeloma doctors in the world!

 

The author Clark Ahlstrom

about the author
Clark Ahlstrom

Clark Ahlstrom is the video team manager for HealthTree University and oversees video production of new HealthTree University videos. He started working at the foundation together with Jenny Ahlstrom, his mother, after her myeloma diagnosis.

More HealthTree University Articles

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Genentech
Abbvie
Bristol Myers Squibb
Janssen Oncology
GSK

Follow Us

facebook instagram twitter youtube

Copyright © 2021 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation / Myeloma Crowd is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811